CoChat

Pens versus syringes to deliver insulin among elderly patients with type 2 diabetes: a randomized controlled clinical trial

Open access
Machry, Rafael Vaz, Cipriani, Gustavo Fonseca, Pedroso, Henrique Umpierre, Nunes, Rafaela Ramos, Pires, Thayme Luisa Souza, Ferreira, Raquel, Vescovi, Betina, de Moura, Gabriela Pereira, Rodrigues, Ticiana Costa · 2021 · Diabetology & Metabolic Syndrome

The DOI matches its Crossref record; 19 of the 19 references it cites were found in a registry or an index.

Abstract

Background: Diabetes mellitus (DM) is a prevalent disease among elderly population. As the disease progresses, insulin may become necessary. The use of pens application seems to be more practical. However, the influence of this method on glycemic control needs to be defined in elderly people. Methods: Randomized clinical trial comparing pens and syringes for insulin application among patients with type 2 DM over 60 years old and Glycated Hemoglobin > 8.5% at baseline. The follow-up was 24 weeks, with monthly medical visits to adjust the treatment. All patients received insulin NPH and, if necessary, insulin Regular. We assessed glycemic control, adherence to treatment, hypoglycemia occurrence, need for adjustment in treatment and impact on quality of life, Results: We included 121 patients with mean age of 65.75 years. Sixty-one were randomized for pen group (PG) and 60 patients for syringe group (SG). At baseline, mean HbA1c was 10.34 ± 1.66% and 9.90 ± 1.25% (p = 0.103) in PG and SG respectively. Mean HbA1c was 8.39 ± 1.28% in PG and 8.85 ± 1.74% in SG (p = 0.101) at 24 weeks. However, there was a more significant reduction in PG (− 1.94 ± 1.93% in PG and − 1.04 ± 1.46% in SG, p < 0.05) during follow-up. We found no difference in treatment adherence rates, hypoglycemia, greater need for insulin doses or oral medication, and progression to basal-bolus insulin scheme. We also found no difference in the impact of the disease on quality of life between groups. Conclusion: Although we did not find any difference in the impact on quality of life, frequency of hypoglycemia or adherence, the PG showed a reduction in HbA1c higher in 24 weeks of follow-up. Clinical trial registration: NCT02517242

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1186/s13098-021-00675-y

Cites

19 of 19 references verified0 citation errors · 0 not checkable

Statistics

Figures

Fig. 1 Glycated hemoglobin (HbA1c). Mean ± SD. § Compare PG with SG at baseline, p = 0.103. ƚ Compare between groups in 12 weeks, p = 0.359. Delta of HbA1c at baseline to 12 weeks: PG vs. SG, p = 0.02. £ Compare between groups in 24 weeks, p = 0.101. Delta of HbA1c at 12 to 24 weeks: PG vs. SG, p = 0.274. Delta of baseline to 24 weeks: PG vs. SG, p = 0.005
Fig. 1 Glycated hemoglobin (HbA1c). Mean ± SD. § Compare PG with SG at baseline, p = 0.103. ƚ Compare between groups in 12 weeks, p = 0.359. Delta of HbA1c at baseline to 12 weeks: PG vs. SG, p = 0.02. £ Compare between groups in 24 weeks, p = 0.101. Delta of HbA1c at 12 to 24 weeks: PG vs. SG, p = 0.274. Delta of baseline to 24 weeks: PG vs. SG, p = 0.005CC BY · PubMed Central
Fig. 2 Incidente of hypoglycemia per week
Fig. 2 Incidente of hypoglycemia per weekCC BY · PubMed Central
Fig. 3 A Body mass index (BMI) Mean ± SD. B Quantity of used insulin per kilo per day. Mean ± SD
Fig. 3 A Body mass index (BMI) Mean ± SD. B Quantity of used insulin per kilo per day. Mean ± SDCC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 19 references

Cited by

See all 13

Metadata

Authors
Machry, R. V., Cipriani, G. F., Pedroso, H. U., Nunes, R. R., Pires, T. L. S., Ferreira, R., Vescovi, B., de Moura, G. P., & Rodrigues, T. C.
Affiliations
  • Universidade Federal do Rio Grande do Sul (BR)
  • Universidade Federal de Santa Maria (BR)
Corresponding author
Machry, Rafael Vaz
Venue
Diabetology & Metabolic Syndrome
Published
2021-06-12
Volume
13
Issue
1
Pages
64-64
ISSN
1758-5996 (ISSN-L)
OpenAlex
W3166144534
Cited by
13
References
18
Citations by year
2025: 4 · 2024: 3 · 2023: 4 · 2022: 1 · 2021: 1
FWCI
1.68
Type
journal article
Language
en
Open access
Licence
Locations
  • Diabetology & Metabolic Syndrome (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
  • LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Científicas) (submittedVersion, cc-by-nc-sa)
Funders
  • CNPq (#4012.68/2013.6)
  • Fundação de Apoio ao Ensino, Pesquisa e Assistência do Hospital das Clínicas da Faculdade de Medicina de Ribeirão Preto da Universidade de São Paulo
Topics
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Education
Keywords
insulin pens, insulin syringes, insulin delivery method, type 2 diabetes, elderly patients, glycemic control, HbA1c, NPH insulin, hypoglycemia, medication adherence, quality of life

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Pens versus syringes to deliver insulin among elderly patients with type 2 diabetes: a randomized controlled clinical trial. https://app.cochat.ai/papers/10.1186/s13098-021-00675-y
The paper
Machry, R. V., Cipriani, G. F., Pedroso, H. U., Nunes, R. R., Pires, T. L. S., Ferreira, R., Vescovi, B., de Moura, G. P., & Rodrigues, T. C. (2021). Pens versus syringes to deliver insulin among elderly patients with type 2 diabetes: a randomized controlled clinical trial. Diabetology & Metabolic Syndrome. https://doi.org/10.1186/s13098-021-00675-y

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.